Skip to main content

Peer Review reports

From: Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction

Original Submission
22 Apr 2022 Submitted Original manuscript
4 May 2022 Reviewed Reviewer Report - Laetitia Michou
17 May 2022 Reviewed Reviewer Report
1 Jun 2022 Author responded Author comments - Dong Dong
Resubmission - Version 2
1 Jun 2022 Submitted Manuscript version 2
5 Jun 2022 Author responded Author comments - Dong Dong
Resubmission - Version 3
5 Jun 2022 Submitted Manuscript version 3
8 Jun 2022 Reviewed Reviewer Report - Laetitia Michou
17 Jun 2022 Reviewed Reviewer Report
28 Jun 2022 Author responded Author comments - Dong Dong
Resubmission - Version 4
28 Jun 2022 Submitted Manuscript version 4
5 Jul 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
6 Jul 2022 Editorially accepted
12 Jul 2022 Article published 10.1186/s12885-022-09864-y

You can find further information about peer review here.

Back to article page